Cargando…
Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients
Adjuvant chemotherapy has been established as standard treatment for advanced cancer among multidisciplinary therapies. A simple and instructive biomarker for therapeutic response and recurrence is needed to evaluate the therapeutic effect. Jab1/COPS5 level has been shown to be associated with tumor...
Autores principales: | Hou, Junna, Liu, Guohong, Yuan, Yufen, Wang, Dong, Jiao, Pengfei, Xing, Lihua, Pan, Yunbao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722579/ https://www.ncbi.nlm.nih.gov/pubmed/29228627 http://dx.doi.org/10.18632/oncotarget.22146 |
Ejemplares similares
-
Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer
por: Liu, Guohong, et al.
Publicado: (2018) -
Pan-cancer analyses of Jab1/COPS5 reveal oncogenic role and clinical outcome in human cancer
por: Wang, Liping, et al.
Publicado: (2022) -
MRPS30-DT Knockdown Inhibits Breast Cancer Progression by Targeting Jab1/Cops5
por: Wu, Balu, et al.
Publicado: (2019) -
Cuproptosis related genes associated with Jab1 shapes tumor microenvironment and pharmacological profile in nasopharyngeal carcinoma
por: Wang, Liping, et al.
Publicado: (2022) -
Stat3 Contributes to Cancer Progression by Regulating Jab1/Csn5 Expression
por: Pan, Yunbao, et al.
Publicado: (2016)